Method for producing genome-edited glycine max plant with reduced phytic acid content by gene editing of gmmips1 and gmmips1h1 and genome-edited glycine max plant with reduced phytic acid content produced thereby

The CRISPR/Cas9 system with optimized guide RNAs effectively edits the GmMIPS1 and GmMIPS1h1 genes in soybeans, achieving substantial phytic acid reduction and stable gene editing, addressing the limitations of previous methods and enhancing soybean value.

WO2026240247A1PCT designated stage Publication Date: 2026-11-19INDUSTRYACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2025/011745
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-12
Filing Date
2025-08-05
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing methods for producing soybean plants with reduced phytic acid content, such as those targeting the GmIPK1 gene, do not address the specific reduction achieved by editing the GmMIPS1 and GmMIPS1h1 genes, and the CRISPR/Cas9 system's efficiency can be enhanced with optimized guide RNAs to ensure stable gene editing and T-DNA-free lines.

Method used

A method using the CRISPR/Cas9 system to edit the GmMIPS1 and GmMIPS1h1 genes in soybean plants, employing guide RNAs (gRNA3 and gRNA4) for precise genome editing, followed by redifferentiation to produce plants with reduced phytic acid content, and a genome editing composition comprising a recombinant vector or complex of guide RNA and endonuclease protein.

Benefits of technology

The method achieves significant reduction in phytic acid content, enhances gene editing efficiency, ensures stability across generations, and facilitates the production of T-DNA-free lines, thereby reducing costs and time compared to GMO crops, and improving the usability and value of soybeans for food and feed.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2025011745_19112026_PF_FP_ABST
    Figure KR2025011745_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to: a method for producing a genome-edited Glycine max plant with a reduced phytic acid content by gene editing of Glycine max-derived GmMIPS1 and GmMIPS1h1 ; and a genome-edited Glycine max plant with a reduced phytic acid content, produced by the method.
Need to check novelty before this filing date? Find Prior Art

Description

Method for producing a genome-edited soybean plant with reduced phytic acid content by editing the GmMIPS1 and GmMIPS1h1 genes, and a genome-edited soybean plant with reduced phytic acid content produced by the said method

[0001] The present invention relates to a method for producing a genome-edited soybean plant with reduced phytic acid content by editing the GmMIPS1 and GmMIPS1h1 genes, and to a genome-edited soybean plant with reduced phytic acid content produced by the said method.

[0002]

[0003] This result was carried out with the support of the Rural Development Administration's Next Generation Crop New Breeding Technology Development Project (Project No.: RS-2024-00322277).

[0004] Soybeans (*Glycine max*) are rich in protein, fat, and dietary fiber, and contain various health-functional substances such as isoflavones, anthocyanins, lecithin, lutein, and saponins. As such, they possess not only high nutritional value as a food but also significant industrial value for use in animal feed and processing. However, soybean seeds contain antinutrients such as phytic acid, which hinders their utilization as a food. Phytic acid is present in large quantities, accounting for approximately 2% of the dry weight of soybean seeds. It is known to bind with minerals such as calcium, iron, and zinc to form precipitates, thereby interfering with mineral absorption and reducing the value of soybeans not only as food but also as animal feed. In particular, livestock manure containing large amounts of phytic acid is known to be a major cause of water pollution resulting from eutrophication. For this reason, the development of soybeans with reduced phytic acid content has significant economic and environmental value, such as enhancing the usability and value of soybeans for food and animal feed and preserving the agricultural environment.

[0005] Meanwhile, among genome editing methods, the CRISPR / Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats / CRISPR associated protein 9) system has recently been attracting attention. Using CRISPR / Cas9 technology, a third-generation gene editing technique, it is possible to specifically edit only the desired genes within a cell in a short period of time. It has been proven to be more accurate and efficient than existing first-generation Zinc Finger Nucleases (ZFNs) and second-generation Transcriptor Activator-Like Effector Nucleases (TALENs), and it has the advantages of simple design and low cost. Furthermore, it has recently been reported that this technology has been successfully used to induce transformation in various plant species, such as tomatoes, grapes, and rice. It has also been confirmed that these mutant individuals are stably transmitted to the next generation.

[0006] The efficiency of such gene editing technology improves depending on the accuracy of locating the complementary base sequence of the target guide RNA (gRNA), and the optimal use of gRNA is an efficient tool for reducing the time, effort, and cost of various scientific studies, such as the production of genetically modified crops.

[0007] Meanwhile, Korean Published Patent No. 2021-0052362 discloses "a composition for producing a soybean protein concentrate with reduced phytic acid and its use," and Korean Registered Patent No. 2704256 discloses "a method for producing a soybean plant with reduced phytic acid content by GmIPK1 gene editing and a genome-edited soybean plant with reduced phytic acid content produced by said method." However, there is no description of the method for producing a genome-edited soybean plant with reduced phytic acid content by GmMIPS1 and GmMIPS1h1 gene editing according to the present invention, nor of the genome-edited soybean plant with reduced phytic acid content produced by said method.

[0008] The present invention was derived from the above-mentioned requirements. The inventors confirmed that the phytic acid content of gene-edited soybean plants produced using a CRISPR / Cas9 system that simultaneously targets soybean-derived GmMIPS1 and GmMIPS1h1 genes is significantly reduced compared to the wild type. Furthermore, the present invention was completed by confirming that using gRNA3 and gRNA4 according to the present invention further enhances gene editing efficiency, ensures that the improved gene editing efficiency remains stable in the next generation, and enables the more effective securing of T-DNA-free lines with completed gene editing.

[0009] To solve the above problem, the present invention provides a method for producing a genome-edited soybean plant with reduced phytic acid content, comprising: (a) a step of correcting the genome by introducing a guide RNA and an endonuclease protein specific to the target nucleotide sequences of soybean-derived GmMIPS1 and GmMIPS1h1 genes into a soybean plant cell; and (b) a step of redifferentiating a soybean plant from the genome-edited soybean plant cell.

[0010] In addition, the present invention provides a genome-edited soybean plant with reduced phytic acid content prepared by the above method and seeds thereof.

[0011] In addition, the present invention provides a genome editing composition for reducing the phytic acid content of a soybean plant, comprising as an active ingredient a recombinant vector comprising DNA encoding a guide RNA specific to the target nucleotide sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target nucleotide sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and an endonuclease protein.

[0012] The method for producing genome-edited plants according to the present invention is expected to save costs and time, unlike GMO crops which require enormous costs and time to evaluate safety and environmental hazards, as the plants do not have external genes inserted and possess only minor mutations indistinguishable from natural variations. Furthermore, since CRISPR gene editing technology introduces mutations in specific genes, it is expected to serve as a permanent method for enhancing quantitative traits.

[0013] In addition, since the manufacturing method of the present invention can effectively secure soybean plants with reduced phytic acid content, it is expected that the usability and value of soybeans for food and feed can be enhanced.

[0014] Figure 1 is a schematic diagram (C) of the target location (A), target sequence (B), and vector of gRNA3 and gRNA4 used for gene editing of GmMIPS1 and GmMIPS1h1 in the present invention.

[0015] FIG. 2 is a schematic diagram (C) of the target location (A), target sequence (B), and vector of gRNA1 and gRNA2 used for gene editing of GmMIPS1 and GmMIPS1h1 in the present invention.

[0016] Figure 3 shows the PCR results confirming the GmMIPS1 and GmMIPS1h1 gene correction in T0 transformants with GmMIPS1 and GmMIPS1h1 gene correction, where A is the result of transformants prepared using gRNA3 and gRNA4, and B is the result of transformants prepared using gRNA1 and gRNA2. W82: Wild-type soybean plant.

[0017] Figure 4 shows the PCR results confirming the GmMIPS1 and GmMIPS1h1 gene correction in T1 transformants with GmMIPS1 and GmMIPS1h1 gene correction, where A is the result of transformants prepared using gRNA3 and gRNA4, and B is the result of transformants prepared using gRNA1 and gRNA2. W82: Wild-type soybean plant.

[0018] Figure 5 shows the results of measuring phytanic acid content in T1-generation and T2-generation seeds of transformants edited with the GmMIPS1 and GmMIPS1h1 genes, where A is the result for transformants prepared using gRNA3 and gRNA4, and B is the result for transformants prepared using gRNA1 and gRNA2. W82: Wild-type soybean plant.

[0019] Figure 6 shows the PCR results confirming the GmMIPS1 and GmMIPS1h1 gene correction in T2 transformants with GmMIPS1 and GmMIPS1h1 gene correction, where A is the result for transformants prepared using gRNA3 and gRNA4, and B is the result for transformants prepared using gRNA1 and gRNA2. W82: Wild-type soybean plant.

[0020] To achieve the objective of the present invention, the present invention comprises the steps of: (a) correcting the genome by introducing a guide RNA and an endonuclease protein specific to the target nucleotide sequences of soybean-derived GmMIPS1 and GmMIPS1h1 genes into soybean plant cells; and

[0021] (b) a step of redifferentiating a soybean plant from a soybean plant cell with the above-mentioned genome edited; the present invention provides a method for producing a genome-edited soybean plant with reduced phytic acid content, comprising: (b) a step of redifferentiating a soybean plant from a soybean plant cell with the above-mentioned genome edited.

[0022] In a method for producing a genome-edited soybean plant with reduced phytic acid content according to one embodiment of the present invention, the soybean-derived GmMIPS1 and GmMIPS1h1 genes may preferably consist of the nucleotide sequences of SEQ ID NO. 1 and SEQ ID NO. 2, respectively, but are not limited thereto.

[0023] In addition, in a method for producing a genome-edited soybean plant with reduced phytic acid content according to one embodiment of the present invention, the target nucleotide sequences of the GmMIPS1 and GmMIPS1h1 genes may consist of the nucleotide sequences of SEQ ID NO. 5 and SEQ ID NO. 6, but are not limited thereto. The nucleotide sequences of SEQ ID NO. 5 and SEQ ID NO. 6 are characterized by targeting both the GmMIPS1 and GmMIPS1h1 genes.

[0024] The term "genome / gene editing" refers to a technology capable of introducing targeted mutations into the genomic sequences of animal and plant cells, including human cells, and involves knocking out or knocking in specific genes by the deletion, insertion, or substitution of one or more nucleic acid molecules through DNA cutting, or introducing mutations into non-coding DNA sequences that do not produce proteins. For the purposes of the present invention, the genome editing may specifically involve introducing mutations into a plant using an endonuclease, such as the Cas9 protein, and a guide RNA.

[0025] The term "target gene" refers to a portion of DNA within the genome of a plant to be corrected through the present invention. That is, in principle, it is not limited to the type of gene and may include both coding and non-coding regions. A person skilled in the art may select the target gene according to the desired variation in the genome-edited plant to be manufactured, depending on the purpose.

[0026] The term "guide RNA" refers to RNA specific to DNA that encodes the base sequence of a target gene, and refers to a ribonucleic acid that binds wholly or partially complementarily to the target DNA base sequence to guide an endonuclease protein to the corresponding target DNA base sequence. The guide RNA refers to a dual RNA comprising two RNAs, namely crRNA (CRISPR RNA) and tracrRNA (trans-activating crRNA), as components; or a single-stranded guide RNA (sgRNA) form comprising a first region containing a sequence wholly or partially complementary to the base sequence within the target DNA and a second region containing a sequence that interacts with the RNA-guide nuclease; however, any form capable of having activity at the target base sequence may be included within the scope of the present invention without limitation. The guide RNA according to the present invention may preferably be in the form of a single-stranded guide RNA, but is not limited thereto, and may be appropriately selected according to known techniques in the art regarding the type of endonuclease used or the microorganism from which the endonuclease originates.

[0027] Additionally, the guide RNA may be transcribed from a plasmid template or transcribed in vitro (e.g., an oligonucleotide double strand), but is not limited thereto.

[0028] In addition, in a manufacturing method according to one embodiment of the present invention, introducing the guide RNA and endonuclease protein of step (a) into a soybean plant cell may utilize a recombinant vector comprising a DNA sequence encoding a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and an endonuclease protein, but is not limited thereto.

[0029] In a manufacturing method according to one embodiment of the present invention, the endonuclease protein may be one or more selected from the group consisting of Cas9 (CRISPR associated protein 9), Cpf1 (CRISPR from Prevotella and Francisella 1), TALEN (Transcription activator-like effector nuclease), ZFN (Zinc Finger Nuclease), or functional analogs thereof, and preferably may be a Cas9 protein, but is not limited thereto.

[0030] Cas9 protein or genetic information can be obtained from known databases such as GenBank of the NCBI (National Center for Biotechnology Information). For example, the Cas9 protein may be one or more selected from the group consisting of Cas9 proteins derived from Streptococcus pyogenes, Cas9 proteins derived from Campylobacter jejuni, Cas9 proteins derived from Streptococcus thermophilus or Streptococcus aureus, Cas9 proteins derived from Neisseria meningitidis, Cas9 proteins derived from Pasteurella multocida, Cas9 proteins derived from Francisella novicida, but is not limited thereto.

[0031] The Cas9 protein is an RNA-guided DNA endonuclease enzyme that induces double-stranded DNA breaks. For the Cas9 protein to accurately bind to the base sequence of the target DNA and cut the DNA strand, a short base sequence consisting of three bases known as PAM (Protospacer Adjacent Motif) must be present next to the base sequence of the target DNA, and the Cas9 protein cuts by estimating the interval between the 3rd and 4th base pairs from the PAM sequence (NGG).

[0032] In a manufacturing method according to one embodiment of the present invention, the guide RNA and the endonuclease protein form a ribonucleoprotein complex and function as an RNA-Guided Engineered Nuclease (RGEN).

[0033] The CRISPR / Cas9 system used in the present invention is a gene correction method based on the NHEJ (non-homologous end joining) mechanism, which induces insertion-deletion (InDel) mutations caused by incomplete repair induced during the DNA repair process by introducing a double helix cut at a specific location of a specific gene to be corrected.

[0034] In the manufacturing method according to the present invention, the method of transfecting the complex of the guide RNA and the endonuclease protein into a plant cell comprises the calcium / polyethylene glycol method for protoplasts (Krens et al., 1982, Nature 296: 72-74; Negrutiu et al., 1987, Plant Mol. Biol. 8: 363-373), the electroporation method for protoplasts (Shillito et al., 1985, Bio / Technol. 3: 1099-1102), the microinjection method into plant elements (Crossway et al., 1986, Mol. Gen. Genet. 202: 179-185), the particle impact method for various plant elements (DNA or RNA-coated) (Klein et al., 1987, Nature 327: 70), and Agrobacterium tumefaciens. It can be appropriately selected from tumefaciens-mediated gene transfer (incompleteness) and infection by a virus (EP 0 301 316), etc.

[0035] In addition, introducing the recombinant vector into a plant cell constitutes a transformation method. Transformation of plant species is now common for plant species including both dicotyledonous and monocotyledonous plants. In principle, any transformation method can be used to introduce the recombinant vector according to the present invention into a suitable progenitor cell.

[0036] The “plant cell” used for the above-mentioned modification may be any plant cell. The plant cell is a cultured cell, cultured tissue, cultured organ, or whole plant. The “plant tissue” includes differentiated or undifferentiated plant tissues, such as, but not limited to, roots, stems, leaves, pollen, seeds, female tissue, and various forms of cells used for culture, namely single cells, protoplasts, shoots, and callus tissue. The plant tissue may be in planta or in organ culture, tissue culture, or cell culture.

[0037] In the manufacturing method of the present invention, any method known in the art may be used for redifferentiating a genome-corrected plant from a genome-corrected plant cell. The genome-corrected plant cell must be redifferentiated into a whole plant. Techniques for redifferentiating mature plants from callus or protoplast cultures are known in the art for numerous different species.

[0038] The present invention also provides a genome-edited soybean plant with reduced phytic acid content produced by the above-described manufacturing method and seeds of said plant.

[0039] The genome-edited soybean plant with reduced phytic acid content according to the present invention is a soybean plant in which the GmMIPS1 and GmMIPS1h1 genes are edited using the CRISPR / Cas9 system, and the soybean-derived GmMIPS1 and GmMIPS1h1 genes are knocked out, resulting in a soybean plant with reduced phytic acid content compared to a soybean plant without genome editing.

[0040] The present invention also provides a genome editing composition for reducing the phytic acid content of a soybean plant, comprising as an active ingredient a recombinant vector comprising a DNA sequence encoding a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and an endonuclease protein.

[0041] In the genome editing composition of the present invention, the target nucleotide sequences of the GmMIPS1 and GmMIPS1h1 genes may consist of the nucleotide sequences of SEQ ID NO. 5 and SEQ ID NO. 6, but are not limited thereto.

[0042] The genome editing composition of the present invention comprises a recombinant vector comprising DNA encoding a guide RNA specific to the target base sequence of the GmMIPS1 and GmMIPS1h1 genes and a nucleic acid sequence encoding an endonuclease protein, or a complex of a guide RNA specific to the target base sequence of the GmMIPS1 and GmMIPS1h1 genes and an endonuclease protein, wherein when the composition is applied to soybean plant cells, the complex of the guide RNA and the endonuclease protein acts as an RNA gene scissors to edit the target gene.

[0043] The genome editing composition of the present invention preferably includes a guide RNA specific to the target nucleotide sequence of the GmMIPS1 and GmMIPS1h1 genes, which consists of the nucleotide sequences of SEQ ID NO. 5 and SEQ ID NO. 6, so that the GmMIPS1 and GmMIPS1h1 genes can be knocked out and the phytic acid content of the soybean plant can be reduced through the knockout of the GmMIPS1 and GmMIPS1h1 genes.

[0044]

[0045] The present invention will be explained in detail below through examples. However, the following examples are merely illustrative of the present invention, and the scope of the present invention is not limited to the following examples.

[0046]

[0047] Materials and Methods

[0048] 1. Plant materials

[0049] Seeds of the soybean (Glycine max) variety Williams 82 were washed under running water for 30 minutes, selected for their normal seed coats, sterilized in 70% (v / v) ethanol for 30 seconds, sterilized in a 1% (v / v) sodium hypochlorite solution for 30 minutes, washed, and then dried to remove excess water. Subsequently, the seeds were placed on a germination medium (B5 medium 3.2 g, sucrose 20 g, MES 0.5 g, agar 8 g, pH 5.7) with the hilum facing downward, and germinated in a 26°C incubator under dark conditions for 20 hours. Afterward, they were grown in a greenhouse under long-term conditions (16 hours light, 8 hours dark).

[0050]

[0051] 2. Vector construction for transformation and soybean transformation

[0052] In order to perform sperm editing targeting the soybean-derived GmMIPS1 (Glyma11g238800) gene and its homolog, GmMIPS1h1 (Glyma18g018600) gene, gRNA3 and gRNA4 that specifically bind to target sequences within the first exon of the GmMIPS1 and GmMIPS1h1 genes were designed using the CRISPRdirect web tool (Table 1, Fig. 1), and the pMDC123_pcoCas9_CRISPR_MIPS1 vector was prepared by inserting gRNA3 and gRNA4 into the pMDC123 vector containing the plant codon-optimized Cas9 gene via golden gate cloning. Subsequently, soybean seeds germinated in a germination medium for 20 hours were split in half using a blade and co-cultured for 4 days with the Agrobacterium tumefaciens EHA105 strain containing the aforementioned pMDC123_pcoCas9_CRISPR_MIPS1 vector. After inoculating onto SEMP5 medium (per 1 L: MS B5 medium 4.4 g, sucrose 30 g, sodium thiosulfate 158 mg, DTT 154 mg, MES 0.6 g, asparagine 50 mg, pyroglutamic acid 100 mg, agar 8 g, zeatin 1 mg, GA3 1 mg, IAA 0.1 mg, cefotaxim 125 mg, thimetin 50 mg, vancomycin 50 mg), the seeds were subcultured, and when the stems elongated to more than 4 cm, the stem portions were cut. Roots were induced in an antibiotic-free root induction medium (per 1 L: MS B5 medium 4.4 g, sucrose 30 g, sodium thiosulfate 158 mg, DTT 154 mg, MES 0.6 g, asparagine 50 mg, pyroglutamic acid 100 mg, agar 8 g, IBA 1 mg, cefotaxim 50 mg, thimetin 50 mg, vancomycin 25 mg). Subsequently, transgenic plants that developed roots from the cut surfaces of the stems were transferred to small pots, acclimatized in plastic containers for 2 weeks, and then transferred to large pots for cultivation in a greenhouse.

[0053]

[0054] Example 1. Preparation of soybean transformants with GmMIPS1 and GmMIPS1h1 genes edited

[0055] Transformers (CT2) with induced GmMIPS1 and GmMIPS1h1 gene editing were produced by co-culturing a strain of Agrobacterium tumopaciens containing a pMDC123_pcoCas9_CRISPR_MIPS1 vector prepared to express gRNA3 and gRNA4 (Table 1, Fig. 1) that simultaneously target soybean-derived GmMIPS1 and GmMIPS1h1 genes with soybean seeds.

[0056] In order to demonstrate that the gene editing efficiency of gRNA3 and gRNA4 according to the present invention is superior to that of other gRNAs, a transformant (CT1) prepared using gRNA1 and gRNA2 (Table 1, Fig. 2) (refer to Korean Registered Patent No. 2573948), which specifically bind to target sequences within the first and third exons of the GmMIPS1 and GmMIPS1h1 genes, was used as a comparison group.

[0057] GmMIPS1 and GmMIPS1h1 gRNA Information Classification gRNA Target Sequence (5'-3') Sequence Number gRNA1 CACGGACTGAATCTCAGTCT3 gRNA2 GGATCCAACTCGGATAGCTG4 gRNA3 GTCTCGGTGTACTTCACATT5 gRNA4CCTGTTCTCGTGAACAAGTT6

[0058]

[0059] Example 2. Analysis of gene editing efficiency

[0060] 2-1. Analysis in Generation T0

[0061] Genomic DNA was extracted from transformants (CT2-T0) prepared using gRNA3 and gRNA4 of the present invention and transformants (CT1-T0) prepared using gRNA1 and gRNA2. PCR was performed on the Bar gene, a selection marker gene within the vector, to confirm whether T-DNA was introduced, and Indel (Insertion / Deletion) PCR was performed on the GmMIPS1 and GmMIPS1h1 genes to confirm whether the GmMIPS1 and GmMIPS1h1 genes were edited.

[0062] As a result, the transformant (CT2-T) prepared using gRNA3 and gRNA4 0- It was confirmed that the GmMIPS1 and GmMIPS1h1 genes of #1) were detected as bands approximately 55 bp smaller in size compared to the wild type (Fig. 3A). This result is due to the target sequence spacing of gRNA3 and gRNA4 being designed to be approximately 55 bp, indicating that the GmMIPS1 and GmMIPS1h1 genes of the individual were successfully corrected. On the other hand, it was confirmed that the GmMIPS1 and GmMIPS1h1 genes of the transformant (CT1-T0) prepared using gRNA1 and gRNA2 were mainly detected as bands similar in size to the wild type (Fig. 3B).

[0063] From the above results, it was found that the gene editing efficiency was further enhanced when using gRNA3 and gRNA4 of the present invention compared to when using gRNA1 and gRNA2.

[0064]

[0065] 2-2. Analysis in the T1 Generation

[0066] After obtaining the T1 generation by advancing the generations of the transformants (CT2-T0-#1) prepared using gRNA3 and gRNA4 of the present invention and the transformants (CT1-T0-#2) prepared using gRNA1 and gRNA2, the genomic DNA of each individual was extracted, and PCR was performed on the Bar gene, which is a selection marker gene within the vector, to confirm whether T-DNA was introduced. Additionally, Indel PCR was performed on the GmMIPS1 and GmMIPS1h1 genes to confirm whether the GmMIPS1 and GmMIPS1h1 genes were edited.

[0067] As a result, it was confirmed that the GmMIPS1 gene of the transformant (CT2-T1-#1-1) prepared using gRNA3 and gRNA4 was detected as a band approximately 793 bp smaller than the wild type, and the GmMIPS1h1 gene was detected as a band approximately 55 bp smaller than the wild type (Fig. 4A), whereas the GmMIPS1 and GmMIPS1h1 genes of the transformants (CT1-T1-#2-7, CT1-T1-#2-9, CT1-T1-#2-10) prepared using gRNA1 and gRNA2 were mainly detected as bands similar in size to the wild type (Fig. 4B).

[0068] From the above results, it was found that the enhanced gene editing efficiency when using gRNA3 and gRNA4 of the present invention was stably maintained in the next generation.

[0069]

[0070] Example 3. Analysis of Phytic Acid Content

[0071] Transformers (CT2-T0-#1) prepared using gRNA3 and gRNA4 of the present invention and transformers (CT1-T0-#2) prepared using gRNA1 and gRNA2 were advanced through generations to obtain seeds of the T1 generation and T2 generation, respectively, and the phytanic acid content in their seeds was measured.

[0072] As a result, it was confirmed that the phytanic acid content of transformants prepared using gRNA3 and gRNA4 (CT2-T1-#1, CT2-T2-#1-1) decreased by 75.5–85.3% compared to the wild type (Fig. 5A), whereas the phytanic acid content of transformants prepared using gRNA1 and gRNA2 (CT1-T2-#2-7, CT1-T2-#2-9, CT1-T2-#2-10) decreased by 37.7–44.5% compared to the wild type (Fig. 5B).

[0073]

[0074] Example 4. Analysis of T-DNA free line securing ability

[0075] The selection of T-DNA-free lines is a crucial factor in line selection, as it allows for the avoidance of GMO regulations by removing the foreign T-DNA gene from the plant genome and prevents additional DNA cleavage or off-target effects caused by continuously expressed Cas9. In transformation using Agrobacterium, T-DNA can be inserted into the plant genome as a single or multiple T-DNA sequence. Insertion of a single T-DNA allows for the easy selection of lines with the T-DNA removed through subsequent generational segregation, but it has the disadvantage of potentially lower gene editing efficiency. Conversely, insertion of multiple T-DNAs can increase gene editing efficiency but has the disadvantage of making it difficult to isolate the T-DNA through generational segregation. Therefore, it is important to insert a small number of T-DNAs containing high-efficiency gRNAs into the genome. According to Mendel's laws of heredity, when one T-DNA is inserted, the segregation ratio can be T-DNA:T-DNA free = 3:1, and when two T-DNAs are inserted, the segregation ratio increases rapidly to T-DNA:T-DNA free = 15:1.

[0076] Accordingly, the generations of the transformant (CT2-T2-#1-1) prepared using gRNA3 and gRNA4 of the present invention and the transformant (CT1-T2-#2-7) prepared using gRNA1 and gRNA2 were advanced, and the genomic DNA of each individual of the T2 generation transformant was extracted. PCR was performed on the Bar gene, which is a selection marker gene within the vector, to confirm whether T-DNA was introduced, and Indel PCR was performed on the GmMIPS1 and GmMIPS1h1 genes to confirm whether the GmMIPS1 and GmMIPS1h1 genes were edited.

[0077] As a result, it was confirmed that when using gRNA3 and gRNA4, two T-DNA free lines with completed gene editing were obtained even though only 9 individuals were advanced for generations, whereas when using gRNA1 and gRNA2, no T-DNA free lines with completed gene editing were obtained even though 20 individuals were advanced for generations (Fig. 6).

[0078] Based on the above results, it was found that using the gRNA3 and gRNA4 of the present invention allows for more effective securing of gene-edited T-DNA free lines.

Claims

1. (a) a step of correcting the genome by introducing a guide RNA and an endonuclease protein specific to the target nucleotide sequences of the soybean-derived GmMIPS1 and GmMIPS1h1 genes into soybean plant cells; and (b) a step of redifferentiating a soybean plant from a soybean plant cell with the above-mentioned genome edited; a method for producing a genome-edited soybean plant with reduced phytic acid content.

2. A method for producing a genome-edited soybean plant with reduced phytic acid content, characterized in that, in claim 1, the target nucleotide sequences of the GmMIPS1 and GmMIPS1h1 genes consist of the nucleotide sequences of SEQ ID NO. 5 and SEQ ID NO.

6.

3. A method for producing a genome-edited soybean plant with reduced phytic acid content, wherein, in claim 1, the introduction of the guide RNA and endonuclease protein of step (a) into a soybean plant cell comprises: a recombinant vector comprising DNA encoding a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and an endonuclease protein.

4. A genome-edited soybean plant with reduced phytic acid content produced by the method of any one of paragraphs 1 to 3.

5. Seeds in which the genome of a soybean plant has been corrected pursuant to Paragraph 4.

6. A genome editing composition for reducing the phytic acid content of a soybean plant, comprising as an active ingredient a recombinant vector comprising a DNA sequence encoding a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and a nucleic acid sequence encoding an endonuclease protein; or a complex of a guide RNA specific to the target base sequence of the soybean-derived GmMIPS1 and GmMIPS1h1 genes and an endonuclease protein.

7. A genome editing composition for reducing the phytic acid content of a soybean plant, characterized in that, in claim 6, the target nucleotide sequences of the GmMIPS1 and GmMIPS1h1 genes consist of the nucleotide sequences of SEQ ID NO. 5 and SEQ ID NO. 6.